Loading…
Ajinomoto North America now offers pharmaceutical-grade L-cystine made by fermentation at its Kawasaki, Japan facility. The product is aimed at pharmaceutical and nutrition customers rather than livestock feed.
This product launch targets a niche pharmaceutical market and does not change feed amino acid supply, demand or prices.
biospace.comGabrielle MassonFeb 16, 2017Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
